Literature DB >> 16889613

Statins down under.

Andrea Mant, Jocelyn Lowinger, Wayne Hall, Susan Whicker, Clare Ringland, Helen Stark.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16889613      PMCID： PMC2000717          DOI： 10.1111/j.1365-2125.2006.02735.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.

Authors:  Andrew Tonkin; Philip Barter; James Best; Andrew Boyden; John Furler; Ken Hossack; David Sullivan; Peter Thompson; Margarite Vale; Catherine Cooper; Malia Robinson; Eleanor Clune
Journal:  Heart Lung Circ       Date:  2005-12       Impact factor: 2.975

2.  Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden.

Authors:  N Magrini; T Einarson; A Vaccheri; P McManus; N Montanaro; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

3.  High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

Authors:  Terje R Pedersen; Ole Faergeman; John J P Kastelein; Anders G Olsson; Matti J Tikkanen; Ingar Holme; Mogens Lytken Larsen; Fredrik S Bendiksen; Christina Lindahl; Michael Szarek; John Tsai
Journal:  JAMA       Date:  2005-11-16       Impact factor: 56.272

4.  Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.

Authors:  T Walley; P Folino-Gallo; P Stephens; E Van Ganse
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

5.  Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study.

Authors:  Nigel P Stocks; Philip Ryan; Heather McElroy; James Allan
Journal:  Med J Aust       Date:  2004-03-01       Impact factor: 7.738
  5 in total
  5 in total

1.  Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population.

Authors:  Gillian E Caughey; Genevieve M Gabb; Saffron Ronson; Michael Ward; Timothy Beukelman; Catherine L Hill; Vidya Limaye
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

2.  Trends in statin therapy initiation during the period 2000-2010 in Israel.

Authors:  Varda Shalev; Clara Weil; Raanan Raz; Inbal Goldshtein; Dahlia Weitzman; Gabriel Chodick
Journal:  Eur J Clin Pharmacol       Date:  2014-01-25       Impact factor: 2.953

3.  Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy.

Authors:  Elisabetta Poluzzi; Petar Strahinja; Monica Lanzoni; Antonio Vargiu; Maria Chiara Silvani; Domenico Motola; Antonio Gaddi; Alberto Vaccheri; Nicola Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

4.  Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.

Authors:  Robyn H Guymer; Paul N Baird; Mary Varsamidis; Lucy Busija; Peter N Dimitrov; Khin Zaw Aung; Galina A Makeyeva; Andrea J Richardson; Lyndell Lim; Liubov D Robman
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans.

Authors:  Cleo Robinson; Helman Alfonso; Samantha Woo; Amy Walsh; Nola Olsen; Arthur W Musk; Bruce W S Robinson; Anna K Nowak; Richard A Lake
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.